Which breathing aid works best for Guillain-Barré? new trial aims to find out
NCT ID NCT06996509
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two breathing support devices—high-velocity nasal cannula (HVNI) and non-invasive ventilation (NIV)—in 80 adults with Guillain-Barré syndrome who have serious breathing trouble. The goal is to see which device helps more patients avoid needing a breathing tube within 30 days. Researchers will also measure comfort, ICU and hospital stays, and survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- High-Velocity Nasal Insufflation (HVNI) device and Non-Invasive Ventilation (NIV) device
- What this could lead to
- If one device works better, it could help more Guillain-Barré patients breathe without needing a breathing tube, reducing complications and hospital stays.
- What could go wrong
- This is a small, early-stage trial (80 patients) at one hospital, so results may not apply to everyone. Both devices are already used, so no major new risks, but individual responses vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUILLAIN-BARRE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assuit Univeristy
RECRUITINGAsyut, Assuit, 71515, Egypt
-
Faculty of Medicine - Assiut University Hospitals - Assiut University - Egypt
RECRUITINGAsyut, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.